These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 417782

  • 21. Antibiotic activity against intraleukocytic Staphylococcus aureus in vitro and in experimental mastitis in mice.
    Craven N, Anderson JC.
    Am J Vet Res; 1983 Apr; 44(4):709-12. PubMed ID: 6553464
    [Abstract] [Full Text] [Related]

  • 22. Bacterial brothers in arms: cooperation of Staphylococcus aureus and Pseudomonas aeruginosa during antimicrobial exposure.
    Lenhard JR, Smith NM, Quach CD, Nguyen TQ, Doan LH, Chau J.
    J Antimicrob Chemother; 2019 Sep 01; 74(9):2657-2665. PubMed ID: 31219553
    [Abstract] [Full Text] [Related]

  • 23. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F, Can F, Azap OK, Demirbilek M, Arslan H, Karaman SO.
    Int J Antimicrob Agents; 2006 Mar 01; 27(3):224-8. PubMed ID: 16464562
    [Abstract] [Full Text] [Related]

  • 24. In vitro antimicrobial efficacy of riboflavin and ultraviolet light on Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, and Pseudomonas aeruginosa.
    Schrier A, Greebel G, Attia H, Trokel S, Smith EF.
    J Refract Surg; 2009 Sep 01; 25(9):S799-802. PubMed ID: 19772254
    [Abstract] [Full Text] [Related]

  • 25. Resistance of Staphylococcus aureus recovered from infected foreign body in vivo to killing by antimicrobials.
    Chuard C, Lucet JC, Rohner P, Herrmann M, Auckenthaler R, Waldvogel FA, Lew DP.
    J Infect Dis; 1991 Jun 01; 163(6):1369-73. PubMed ID: 1903801
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Interactions of antimicrobial compounds with cross-linking agents of alginate dressings.
    Goh CH, Heng PW, Huang EP, Li BK, Chan LW.
    J Antimicrob Chemother; 2008 Jul 01; 62(1):105-8. PubMed ID: 18408234
    [Abstract] [Full Text] [Related]

  • 28. Comparative activity of cloxacillin and vancomycin against methicillin-susceptible Staphylococcus aureus experimental endocarditis.
    Fernández Guerrero ML, de Górgolas M.
    J Antimicrob Chemother; 2006 Nov 01; 58(5):1066-9. PubMed ID: 16931540
    [Abstract] [Full Text] [Related]

  • 29. Maggot excretions/secretions are differentially effective against biofilms of Staphylococcus aureus and Pseudomonas aeruginosa.
    van der Plas MJ, Jukema GN, Wai SW, Dogterom-Ballering HC, Lagendijk EL, van Gulpen C, van Dissel JT, Bloemberg GV, Nibbering PH.
    J Antimicrob Chemother; 2008 Jan 01; 61(1):117-22. PubMed ID: 17965032
    [Abstract] [Full Text] [Related]

  • 30. In vitro and in vivo activities of echinomycin against clinical isolates of Staphylococcus aureus.
    Park YS, Shin WS, Kim SK.
    J Antimicrob Chemother; 2008 Jan 01; 61(1):163-8. PubMed ID: 17967852
    [Abstract] [Full Text] [Related]

  • 31. Experimental study on the efficacy of combinations of glycopeptides and beta-lactams against Staphylococcus aureus with reduced susceptibility to glycopeptides.
    Domenech A, Ribes S, Cabellos C, Taberner F, Tubau F, Domínguez MA, Montero A, Liñares J, Ariza J, Gudiol F.
    J Antimicrob Chemother; 2005 Oct 01; 56(4):709-16. PubMed ID: 16120625
    [Abstract] [Full Text] [Related]

  • 32. 3-Amino-4-aminoximidofurazan derivatives: small molecules possessing antimicrobial and antibiofilm activity against Staphylococcus aureus and Pseudomonas aeruginosa.
    Das MC, Paul S, Gupta P, Tribedi P, Sarkar S, Manna D, Bhattacharjee S.
    J Appl Microbiol; 2016 Apr 01; 120(4):842-59. PubMed ID: 26785169
    [Abstract] [Full Text] [Related]

  • 33. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
    Cetinkaya E, Coban AY, Durupinar B.
    Mikrobiyol Bul; 2008 Oct 01; 42(4):553-61. PubMed ID: 19149076
    [Abstract] [Full Text] [Related]

  • 34. [An experimental study on pyogenic osteomyelitis with special reference to polymicrobial infections].
    Hidaka S.
    Nihon Seikeigeka Gakkai Zasshi; 1985 Apr 01; 59(4):429-41. PubMed ID: 3928778
    [Abstract] [Full Text] [Related]

  • 35. Activity of N-acetyl-L-cysteine against biofilm of Staphylococcus aureus and Pseudomonas aeruginosa on orthopedic prosthetic materials.
    Drago L, De Vecchi E, Mattina R, Romanò CL.
    Int J Artif Organs; 2013 Jan 01; 36(1):39-46. PubMed ID: 23280076
    [Abstract] [Full Text] [Related]

  • 36. Controlled release and antibacterial activity chlorhexidine acetate (CA) intercalated in montmorillonite.
    Meng N, Zhou NL, Zhang SQ, Shen J.
    Int J Pharm; 2009 Dec 01; 382(1-2):45-9. PubMed ID: 19666092
    [Abstract] [Full Text] [Related]

  • 37. The disulfiram metabolites S-methyl-N,N-diethyldithiocarbamoyl sulfoxide and S-methyl-N,N-diethylthiocarbamoyl sulfone irreversibly inactivate betaine aldehyde dehydrogenase from Pseudomonas aeruginosa, both in vitro and in situ, and arrest bacterial growth.
    Zaldívar-Machorro VJ, López-Ortiz M, Demare P, Regla I, Muñoz-Clares RA.
    Biochimie; 2011 Feb 01; 93(2):286-95. PubMed ID: 20933050
    [Abstract] [Full Text] [Related]

  • 38. Hyperbranched poly(NIPAM) polymers modified with antibiotics for the reduction of bacterial burden in infected human tissue engineered skin.
    Shepherd J, Sarker P, Rimmer S, Swanson L, MacNeil S, Douglas I.
    Biomaterials; 2011 Jan 01; 32(1):258-67. PubMed ID: 20933276
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.